Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001415889-24-018082
Filing Date
2024-06-24
Accepted
2024-06-24 20:23:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4062
  Complete submission text file 0001415889-24-018082.txt   5568
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Subject) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38150 | Film No.: 241065960
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O DYAX CORP. 55 NETWORK DRIVE BURLINGTON MA 01803
Business Address
Bazemore Todd (Reporting) CIK: 0001605767 (see all company filings)

Type: 144